{"id":268,"date":"2020-02-18T18:39:11","date_gmt":"2020-02-18T09:39:11","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/?page_id=268"},"modified":"2020-06-11T13:13:07","modified_gmt":"2020-06-11T04:13:07","slug":"2019-2","status":"publish","type":"page","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/works\/2019-2\/","title":{"rendered":"2019"},"content":{"rendered":"

\u539f\u8457\u8ad6\u6587<\/strong><\/p>\n

    \n
  1. Kuroiwa Y, Uchida A, Yamashita A, Miyati T, Maekawa K, Gi T, Noguchi T, Yasuda S, Imamura T, Asada Y. Coronary high-signal-intensity plaques on T1-weighted magnetic resonance imaging reflect intraplaque hemorrhage. Cardiovasc Pathol. 2019;40:24-31.<\/li>\n
  2. Maekawa K, Sugita C, Yamashita A, Moriguchi-Goto S, Furukoji E, Sakae T, Gi T, Hirai T, Asada Y. Higher lactate and purine metabolite levels in erythrocyte-rich fresh venous thrombus: Potential markers for early deep vein thrombosis. Thromb Res. 2019;177:136-144.<\/li>\n
  3. Furukoji E,\u00a0Yamashita A, Nakamura K, Hirai T,\u00a0Asada Y. Podoplanin expression on endothelial cells promotes superficial erosive injury and thrombus formation in rat carotid artery: Implications for plaque erosion. Thromb Res. 2019;183:76-79.<\/li>\n
  4. Sato Y, Maekawa K, Aman M,\u00a0Yamashita A, Kodama Y, Maki Y, Sameshima H,\u00a0Asada Y. CD39 downregulation in chronic intervillositis of unknown etiology. Virchows Arch. 2019;475(3):357-364.<\/li>\n
  5. Nakahara K, Yamasaki K, Nagai T, Fujii M, Akioka T, Takamori H, Terada N, Mukai S, Sato Y, Kamoto T. Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis. Res Rep Urol. 2019;11:97-104.<\/li>\n
  6. Adhikara IM, Yagi K, Mayasari DS, Ikeda K, Kitagawa H, Miyata O, Igarashi M, Hatakeyama K, Asada Y, Hirata KI, Emoto N. Chondroitin sulfate N-acetylgalactosaminyltransferase-2 deletion alleviates lipoprotein retention in early atherosclerosis and attenuates aortic smooth muscle cell migration. Biochem Biophys Res Commun. 2019;509:89-95.<\/li>\n
  7. Nishino S, Watanabe N, Ashikaga K, Morihisa K, Kuriyama N, Asada Y, Shibata Y. Reverse Remodeling of the Mitral Valve Complex After Radiofrequency Catheter Ablation for Atrial Fibrillation: A Serial 3-Dimensional Echocardiographic Study. Circ Cardiovasc Imaging. 2019;12:e009317.<\/li>\n
  8. Jiang D, Kawagoe Y, Asada Y, Kitamura K, Kato J. Augmented blood pressure variability following continuous infusion of noradrenaline in rats. J Hypertens. 2019;38:314-21.<\/li>\n
  9. Tsuruda T, Funamoto T, Udagawa N, Kurogi S, Nakamichi Y, Koide M, Chosa E, Asada Y, Kitamura K. Blockade of the angiotensin II type 1 receptor increases bone mineral density and left ventricular contractility in a mouse model of juvenile Paget disease. Eur J Pharmacol. 2019;859:172519.<\/li>\n<\/ol>\n

    \u75c7\u4f8b\u5831\u544a<\/strong><\/p>\n

      \n
    1. Sato Y, Yamaguchi T, Muraoka J, Taniguchi H, Kisanuki A, Maekawa K, Yamashita A, Aman M, Kodama Y, Sameshima H, Asada Y. C4d Deposition in Fetal Vessels of the Placenta in Neonatal Lupus Syndrome. Case Rep Obstet Gynecol. 2019;2019:5863476.<\/li>\n
    2. Nishihira K,\u00a0Yamashita A, Kataoka Y, Shibata Y,\u00a0Asada Y. Visualization of oxidized low-density lipoprotein at lipid-rich plaque in a ST-segment elevation myocardial infarction case with heterozygous familial hypercholesterolaemia: insights from near-infrared spectroscopy and histopathological analysis. Eur Heart J Cardiovasc Imaging. 2019;20:1316.<\/li>\n
    3. Doi S, Kuroiwa Y, Kusumoto K,\u00a0Yamashita A, Furukoji E, Tai H, Kihara Y, Hirai T,\u00a0Asada Y, Imamura T. Therapeutic response of immunoglobulin 4-related aortitis and pancreatitis demonstrated by diffusion-weighted MRI. Radiol Case Rep. 2019;14:1132-1135.<\/li>\n
    4. Tsuruda T, Sato Y, Kajihara K, Kawabata T, Kubuki Y, Komaki S, Kikuchi M Ishikawa T, Tono T, Kitamura K. Non-canonical expression of cardiac troponin-T in neuroendocrine ethmoid sinus carcinoma following immune checkpoint blockade. Frontiers in Cardiovascular Medicine, section Cardio-Oncology. 2019;6:124.<\/li>\n
    5. Ogata S, Maeda R, Tomita M, Sato Y, Ayabe T, Nakamura K. Resected thymic large cell neuroendocrine carcinoma: A case reportand review of the literature. Int. J. Surg. Case Rep. 2019; 60:53.<\/li>\n
    6. Ban T, Kawakami H, Kubota Y, Nanashima A, Yano K, Sato Y. The development of gastric outlet obstruction due to a lumen-occupying protruding duodenal ulcer mimicking a submucosal tumor. Intern Med. 2019;58:1267-1271.<\/li>\n
    7. Higuchi K, Furukawa K, Nakamura E, Nakamura E, Asada Y, Nakada H, Nakamura H. Right atrial blood cyst incidentally detected by computed tomography for metastatic breast cancer in an adult female patient: A case report. World J Cardiovasc Surg. 2019; 9: 47-51<\/li>\n<\/ol>\n

      \u7dcf\u8aac<\/strong><\/p>\n

        \n
      1. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u80ce\u76e4I \u3000\u80ce\u76e4\u75c5\u7406\u8a3a\u65ad\u3000\u57fa\u790e\u7de8\uff1a\u80ce\u76e4\u3067\u89b3\u5bdf\u3055\u308c\u308b\u51fa\u8840\u30fb\u51fa\u8840\u69d8\u5909\u5316\u3001\u7d68\u6bdb\u9593\u8840\u6813\u3001\u7d68\u6bdb\u819c\u4e0b\u8840\u6813\u3001\u80ce\u76e4\u5f8c\u8840\u816b\u3001\u3073\u307e\u3093\u6027\u7d68\u6bdb\u819c\u7f8a\u819c\u30d8\u30e2\u30b8\u30c7\u30ed\u30fc\u30b7\u30b9(DCH) \u75c5\u7406\u3068\u81e8\u5e8a. 2019; 37:865-871.<\/li>\n
      2. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u80ce\u76e4I I\u3000\u80ce\u76e4\u75c5\u7406\u8a3a\u65ad\u3000\u5fdc\u7528\u7de8\uff1a\u539f\u56e0\u4e0d\u660e\u306e\u6162\u6027\u7d68\u6bdb\u708e\u3068\u7d68\u6bdb\u9593\u708e\u3000\u75c5\u7406\u3068\u81e8\u5e8a. 2019; 37:953-960,<\/li>\n
      3. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u80ce\u76e4\u75c5\u7406\u3068\u8840\u6db2\u51dd\u56fa. \u65e5\u672c\u7523\u5a66\u4eba\u79d1\u30fb\u65b0\u751f\u5150\u8840\u6db2\u5b66\u4f1a\u8a8c, 2019;28:25-30.<\/li>\n
      4. \u9b4f\u3000\u5cfb\u6d38\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce.\u9759\u8108\u8840\u6813\u75c7\u306e\u75c5\u7406. \u30ab\u30ec\u30f3\u30c8\u30c6\u30e9\u30d4\u30fc 2019;37:42-47<\/li>\n
      5. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u8840\u7ba1\u708e\u75c7\u306e\u5236\u5fa1\u306b\u3088\u308b\u5fc3\u8840\u7ba1\u75c5\u306e\u6291\u5236\u3068\u8840\u6813\u75c7\u306e\u75c5\u7406\u3001\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u96d1\u8a8c2019; 30 : 837-844.<\/li>\n
      6. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u8840\u6813\u5f62\u6210\u3068\u52d5\u8108\u786c\u5316\u3001\u65e5\u672c\u533b\u5e2b\u4f1a\u96d1\u8a8c 2019;148:S340-S342<\/li>\n<\/ol>\n

        \u8457\u66f8<\/strong><\/p>\n

          \n
        1. Sato Y: Placental pathology. In; Preterm Labor and Delivery. Sameshima H (ed)., 225-243, 2019, Springer<\/li>\n
        2. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u9759\u8108\u306e\u767a\u751f\u3068\u89e3\u5256.\u65b0\u81e8\u5e8a\u9759\u8108\u5b66.\u65e5\u672c\u9759\u8108\u5b66\u4f1a\u7de8. 7-9, 2019, \u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e.<\/li>\n
        3. \u524d\u5ddd\u548c\u4e5f\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u7279\u6b8a\u306a\u9759\u8108\uff08\u8178\u7ba1\u9759\u8108\u3084\u9580\u8108\u306a\u3069\uff09.\u65b0\u81e8\u5e8a\u9759\u8108\u5b66.\u65e5\u672c\u9759\u8108\u5b66\u4f1a\u7de8. 12-13, 2019, \u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e.<\/li>\n
        4. \u9b4f\u3000\u5cfb\u6d38\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u6025\u6027\u80ba\u8840\u6813\u585e\u6813\u75c7.\u65b0\u81e8\u5e8a\u9759\u8108\u5b66.\u65e5\u672c\u9759\u8108\u5b66\u4f1a\u7de8. 398-399, 2019, \u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e<\/li>\n<\/ol>\n

          \u5b66\u4f1a\u767a\u8868<\/strong><\/p>\n

            \n
          1. \u6749\u7530\u5343\u6cf0\u3001\u5927\u576a\u8ce2\u6cbb\u3001\u84b2\u751f\u7f8e\u7d17\u5b50\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u5409\u7530\u88d5\u6a39\u3001\u5c71\u672c\u9686\u4e00\u3001\u9ed2\u5ddd\u660c\u5f66. \u30b8\u30aa\u30b9\u30df\u30f3\u3068\u30b8\u30aa\u30b9\u30e1\u30c1\u30f3\u306e\u8840\u5c0f\u677f\u304a\u3088\u3073\u51dd\u56fa\u7cfb\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306e\u6bd4\u8f03. \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c139\u5e74\u4f1a\uff08\u5343\u8449\u5e02\u30013\/20-23, 2019\uff09<\/li>\n
          2. \u67f3 \u91cd\u4e45, \u5b87\u90fd\u52a0\u5bff\u5b50, \u9b4f \u5cfb\u6d38, \u576a\u5185\u62e1\u4f38, \u702c\u6238\u53e3\u5065\u4ecb, \u4f50\u85e4\u52c7\u4e00\u90ce, \u677e\u5143 \u4fe1\u5f18, \u6d45\u7530\u7950\u58eb\u90ce, \u4e2d\u91cc \u96c5\u5149\u7d4c\u6642\u7684\u5909\u5316\u3092\u89b3\u5bdf\u3057, KRAS\u5909\u7570\u89e3\u6790\u306b\u3088\u308a\u8a3c\u660e\u3057\u5f97\u305f\u591a\u767a\u6027\u6d78\u6f64\u6027\u7c98\u6db2\u817a\u764c\u3092\u8d77\u6e90\u3068\u3059\u308b\u30e9\u30d6\u30c9\u30a4\u30c9\u5f62\u8cea\u968f\u4f34\u5927\u7d30\u80de\u764c\u306e\u4e00\u5256\u691c\u4f8b. \u7b2c59\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff08\u6771\u4eac, 4\/12-14, 2019\uff09<\/li>\n
          3. \u8ca1\u90e8\u611b\u83dc, \u6301\u7530\u8015\u4ecb, \u9b4f \u5cfb\u6d38, \u65b0\u4e95\u6804\u4e00, \u5929\u91ce\u6b63\u5b8f. \u53f3\u3053\u3081\u304b\u307f\u90e8\u306e\u9ed2\u8272\u6591. \u7b2c35\u56de\u65e5\u672c\u76ae\u819a\u75c5\u7406\u7d44\u7e54\u5b66\u4f1a\uff08\u6771\u4eac, 4\/20-21, 2019\uff09<\/li>\n
          4. Yamashita A, Nishihira K, Maekawa K, Gi T, Hatakeyama K, Shibata Y, Asada Y. Histological features of ruptured plaque and thrombus interface in acute myocardial infarction. ATVB\/PVD2018 (Boston, May 5-7, 2019)<\/li>\n
          5. Maekawa K, Yamashita A, Azuma M, Enzaki M, Yokogami K, Takeshima H, Wang Y, Hirai T, Asada A. Quantitative susceptibility mapping on magnetic resonance imaging distinguishes intraplaque hemorrhage and iron deposition from calcification in carotid atherosclerosis. ATVB\/PVD2018 (Boston, 5\/5-7, 2019)<\/li>\n
          6. \u5c71\u4e0b\u3000\u7be4\u3001\u6e21\u908a\u88d5\u8cb4\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u5317\u6751\u548c\u96c4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u30ad\u30cc\u30ec\u30cb\u30f3\u4ee3\u8b1d\u9175\u7d20\u30a4\u30f3\u30c9\u30fc\u30eb\u30a2\u30df\u30f32,3\u30b8\u30aa\u30ad\u30b7\u30b2\u30ca\u30fc\u30bc1\u306e\u6025\u6027\u51a0\u75c7\u5019\u7fa4\u306b\u304a\u3051\u308b\u95a2\u4e0e. \u7b2c108\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\uff08\u6771\u4eac\u30015\/9-11, 2019\uff09<\/li>\n
          7. \u524d\u5ddd\u548c\u4e5f\u3001\u6771\u3000\u7f8e\u83dc\u5b50\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u5e73\u4e95\u4fca\u7bc4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u9838\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306e\u7d44\u7e54\u50cf\u3068\u78c1\u6c17\u5171\u9cf4\u753b\u50cf\u306b\u304a\u3051\u308b\u5b9a\u91cf\u7684\u78c1\u5316\u7387\u30de\u30c3\u30d4\u30f3\u30b0\u3068\u306e\u5bfe\u6bd4. \u7b2c108\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\uff08\u6771\u4eac\u30015\/9-11, 2019\uff09<\/li>\n
          8. \u5927\u6817\u4f38\u4e4b\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u963f\u842c\u3000\u7d2b\u3001\u5ca9\u5207\u5f18\u76f4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u5fc3\u819c\u6b20\u640d\u3078\u306e\u5fc3\u5d4c\u9813\u306b\u3088\u308b\u6025\u6027\u5fc3\u7b4b\u6897\u585e\u306e\u4e00\u4f8b. \u7b2c108\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\uff08\u6771\u4eac\u30015\/9-11, 2019\uff09<\/li>\n
          9. \u65e5\u9ad8\u8cb4\u5b50, \u9b4f \u5cfb\u6d38, \u67ca\u5c71 \u5270, \u6fa4\u7530 \u60c7, \u4e2d\u99ac\u79c0\u6a39, \u76f4\u4e95\u4fe1\u4e45. \u8d85\u97f3\u6ce2\u691c\u67fb\u304c\u8a3a\u65ad\u306e\u4e00\u52a9\u3068\u306a\u3063\u305f\u591a\u91cf\u7db2\u8108\u7d61\u819c\u4e0b\u8840\u816b\u3092\u8a8d\u3081\u305f\u7d9a\u767a\u9589\u585e\u9685\u89d2\u7dd1\u5185\u969c\u306e\u4e00\u4f8b. \u7b2c92\u56de\u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u6771\u4eac, 5\/24-26, 2019\uff09<\/li>\n
          10. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u5fb3\u6e80\u8cb4\u5b50, \u91ce\u53e3\u88d5\u53f2, \u5927\u91ce\u62db\u4f38, \u68ee\u7530\u52dd\u4ee3, \u5cf0\u677e\u6620\u5b50, \u9ed2\u6728\u6804\u8f1d, \u963f\u842c\u7d2b, \u524d\u5ddd\u548c\u4e5f\u3001\u4f50\u85e4\u4fe1\u4e5f. \u8853\u4e2d\u7d30\u80de\u8a3a\u306e\u8840\u7ba1\u50cf\u304b\u3089glioma\u3092\u63a8\u5b9a\u3057\u3048\u305f\u8133\u816b\u760d\u306e1\u4f8b. \u7b2c60\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7dcf\u4f1a (\u6771\u4eac\u30016\/7-9, 2019)<\/li>\n
          11. \u767d\u6ff1\u5e78\u751f\u3001\u6e05\u5c71\u548c\u662d\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6817\u6797\u5fe0\u4fe1. \u6162\u6027\u7532\u72b6\u817a\u708e\u304b\u3089\u306e\u79fb\u884c\u304c\u63a8\u5b9a\u3055\u308c\u305f\u7532\u72b6\u817a\u539f\u767a\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e2\u75c7\u4f8b. \u5145\u5b9f\u578b\u4e73\u982d\u764c\u306e1\u4f8b. \u7b2c60\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u7dcf\u4f1a (\u6771\u4eac\u30016\/7-9, 2019)<\/li>\n
          12. \u5c71\u4e0b\u3000\u7be4\u3001\u6e21\u908a\u88d5\u8cb4\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u5317\u6751\u548c\u96c4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u30ad\u30cc\u30ec\u30cb\u30f3\u4ee3\u8b1d\u9175\u7d20\u30a4\u30f3\u30c9\u30fc\u30eb\u30a2\u30df\u30f32,3\u30b8\u30aa\u30ad\u30b7\u30b2\u30ca\u30fc\u30bc1\u306f\u51a0\u52d5\u8108\u786c\u5316\u5de3\u306e\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u306b\u767a\u73fe\u3057\u305d\u306e\u51dd\u56fa\u6d3b\u6027\u306e\u4ea2\u9032\u306b\u95a2\u4e0e\u3059\u308b. \u7b2c41\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u6d25\u5e02\u30016\/20-22, 2019\uff09<\/li>\n
          13. Yamashita A, Nishihira K, Maekawa K, Gi T, Hatakeyama K, Shibata Y, Asada Y. Pathological features of ruptured atherosclerotic plaque and thrombus interface in acute myocardial infarction. 27th Congress of International Society on Thrombosis and Haemostasis, (Melbourne, July 6-10, 2019)<\/li>\n
          14. Gi T, Yamashita A, Kuroiwa Y, Konishi Y, Asanuma Y, Imamura T, Asada Y. Non-invasive detection of early phase of deep vein thrombus with diffusion-weighted magnetic resonance imaging. 27th Congress of International Society on Thrombosis and Haemostasis, (Melbourne, July 6-10, 2019)<\/li>\n
          15. Kuroiwa Y, Uchida A, Yamashita A, Miyati T, Maekawa K, Gi T, Noguchi T, Yasuda S, Imamura T, Asada Y. Coronary high-signal-intensity plaques on T1<\/sub>-weighted magnetic resonance imaging reflect intraplaque hemorrhage: A novel marker for plaque instability and thrombogenic potential.27th Congress of International Society on Thrombosis and Haemostasis, (Melbourne, July 6-10, 2019)<\/li>\n
          16. Kuga N, Kuroiwa Y, Sakamoto T, Yamashita A, Gi T, Doi S, Kinoshita T, Tanaka T, Kihara Y, Asada Y, Imamura T. A signal change of jugular vein thrombus on diffusion weighted MR imaging. \u7b2c47\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff08\u718a\u672c\u5e02\u30019\/20-22, 2019\uff09<\/li>\n
          17. \u9ebb\u7530\u8cb4\u5fd7\u3001\u7532\u6590\u771e\u5f18\u3001\u91d1\u4e38\u5e79\u90ce\u3001\u5c71\u4e0b\u3000\u7be4. CA19-9\u7570\u5e38\u9ad8\u5024\u3092\u5448\u3057\u305f\u9ec4\u8272\u8089\u82bd\u816b\u6027\u80c6\u56a2\u708e\u306e1\u4f8b. \u7b2c55\u56de\u65e5\u672c\u80c6\u9053\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u540d\u53e4\u5c4b\u5e02, 10\/3,4, 2019\uff09<\/li>\n
          18. \u9b4f \u5cfb\u6d38, \u5c71\u4e0b \u7be4, \u9ed2\u5ca9\u9756\u6df3, \u6c34\u8c37\u7950\u5b50, \u6d45\u6cbc\u6b66\u654f, \u4eca\u6751\u5353\u90ce, \u6d45\u7530\u7950\u58eb\u90ce. \u62e1\u6563\u5f37\u8abf\u753b\u50cf\u3092\u7528\u3044\u305f\u6df1\u90e8\u9759\u8108\u8840\u6813\u306e\u63cf\u51fa\u306a\u3089\u3073\u306b\u6642\u76f8\u8a55\u4fa1\u306e\u691c\u8a0e. \u7b2c60\u56de\u65e5\u672c\u8108\u7ba1\u5b66\u4f1a\u7dcf\u4f1a\uff08\u6771\u4eac, 10\/10-12, 2019\uff09<\/li>\n
          19. \u5c71\u4e0b\u3000\u7be4\uff0c\u897f\u5e73\u8ce2\u4f5c\uff0c\u524d\u5ddd\u548c\u4e5f\u3001\u9b4f\u5cfb\u3000\u6d38\u3001\u7560\u5c71\u91d1\u592a\u3001\u67f4\u7530\u525b\u5fb3\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u7834\u88c2\u3057\u305f\u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306e\u8840\u6813\u5883\u754c\u90e8\u306e\u75c5\u7406\u6240\u898b. \u7b2c24\u56de\u65e5\u672c\u8840\u7ba1\u75c5\u7406\u7814\u7a76\u4f1a\uff08\u677e\u672c\u300111\/2, 2019\uff09<\/li>\n
          20. \u6728\u6751\u53cb\u54c9, \u9ad8\u68ee\u5927\u6a39, \u5ca1\u90e8 \u6d38, \u5927\u585a\u6b66, \u6728\u6751\u7fd4\u4e00, \u98db\u7530\u5353\u54c9, \u79cb\u5ca1\u8cb4\u5f18, \u5bfa\u7530 \u76f4\u6a39, \u6728\u7530\u548c\u8cb4, \u4e0a\u6751\u654f\u96c4, \u5411\u4e95\u5c1a\u4e00\u90ce, \u9b4f \u5cfb\u6d38, \u4f50\u85e4\u52c7\u4e00\u90ce, \u8cc0\u672c\u654f\u884c. \u8089\u816b\u69d8\u5909\u5316\u3092\u4f34\u3046\u672a\u6cbb\u7642\u9032\u884c\u6027\u814e\u764c\u306b\u5bfe\u3057\u30a4\u30d4\u30ea\u30e0\u30de\u30d6\u30fb\u30cb\u30dc\u30eb\u30de\u30d6\u4f75\u7528\u7642\u6cd5\u3092\u65bd\u884c\u3057\u305f\u4e00\u4f8b. \u7b2c71\u56de\u897f\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a\uff08\u5cf6\u6839, 11\/7-10, 2019\uff09<\/li>\n
          21. \u91ce\u53e3\u88d5\u53f2, \u5fb3\u6e80\u8cb4\u5b50, \u5927\u91ce\u62db\u4f38, \u68ee\u7530\u52dd\u4ee3, \u5cf0\u677e\u6620\u5b50, \u9ed2\u6728\u6804\u8f1d, \u9b4f\u5cfb\u6d38, \u4f50\u85e4\u52c7\u4e00\u90ce. \u80baCT\u30ac\u30a4\u30c9\u4e0b\u91dd\u751f\u691c\u306e\u637a\u5370\u7d30\u80de\u8a3a\u306b\u304a\u3044\u3066\u9ac4\u5916\u9020\u8840\u3092\u63a8\u5b9a\u3057\u3048\u305f1\u75c7\u4f8b. \u7b2c58\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u671f\u5927\u4f1a\uff08\u5ca1\u5c71, 11\/16-17, 2019\uff09<\/li>\n
          22. \u5927\u91ce\u62db\u4f38\u3001\u91ce\u53e3\u88d5\u53f2, \u5fb3\u6e80\u8cb4\u5b50, \u5cf0\u677e\u6620\u5b50, \u68ee\u7530\u52dd\u4ee3, ,\u9ed2\u6728\u6804\u8f1d, \u4f50\u85e4\u52c7\u4e00\u90ce. EUS-FNA\u3067\u80c3\u7c98\u819c\u4e0b\u795e\u7d4c\u9798\u816b\u306e\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f1\u4f8b. \u7b2c58\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u5b63\u5927\u4f1a\uff08\u5ca1\u5c71, 11\/16-17, 2019\uff09<\/li>\n
          23. \u9ed2\u6728\u6804\u8f1d, \u5fb3\u6e80\u8cb4\u5b50, \u68ee\u7530\u52dd\u4ee3,\u5cf0\u677e\u6620\u5b50, \u5927\u91ce\u62db\u4f38, \u91ce\u53e3\u88d5\u53f2, \u7530\u4e2d\u5f18\u4e4b, \u4f50\u85e4\u52c7\u4e00\u90ce. \u9ac4\u6db2\u4e2d\u306b\u9aa8\u9ac4\u816b\u7d30\u80de\u306e\u6d78\u6f64\u304c\u7591\u308f\u308c\u305f\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e1\u4f8b. \u7b2c58\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u5b63\u5927\u4f1a\uff08\u5ca1\u5c71, 11\/16-17, 2019\uff09<\/li>\n
          24. \u9b4f\u3000\u5cfb\u6d38\u3001\u7532\u6590\u8aa0\u7ae0\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u9db4\u7530\u654f\u535a\u3001\u7560\u5c71\u91d1\u592a\u3001\u77f3\u5ddd\u54f2\u61b2\u3001\u4f50\u85e4\u3000\u52c7\u4e00\u90ce\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u95a2\u9023\u5fc3\u7b4b\u708e\u306e\u4e00\u75c7\u4f8b. \u7b2c65\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u79cb\u671f\u7279\u5225\u7dcf\u4f1a\uff08\u5e83\u5cf6, 11\/27-28, 2019\uff09<\/li>\n
          25. \u9b4f\u3000\u5cfb\u6d38\u3001\u7532\u6590\u8aa0\u7ae0\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u9db4\u7530\u654f\u535a\u3001\u7560\u5c71\u91d1\u592a\u3001\u77f3\u5ddd\u54f2\u61b2\u3001\u4f50\u85e4\u3000\u52c7\u4e00\u90ce\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u95a2\u9023\u5fc3\u7b4b\u708e\u306e\u4e00\u75c7\u4f8b. \u7b2c41\u56de\u5fc3\u7b4b\u751f\u691c\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u4eac\u90fd, 12\/6-7, 2019\uff09<\/li>\n<\/ol>\n

            \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/strong><\/p>\n

              \n
            1. \u5c71\u4e0b\u3000\u7be4\uff1a\u51a0\u52d5\u8108\u75be\u60a3\u306b\u304a\u3051\u308b\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0. \u51a0\u52d5\u8108\u306e\u8840\u6813\u5f62\u6210\u80fd\u8a55\u4fa1\u306b\u7e4b\u304c\u308b\u8840\u7ba1\u4ee3\u8b1d\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0. \u7b2c29\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a.\uff08\u4e45\u7559\u7c73\u5e02\u30011\/25-26, 2019\uff09<\/li>\n
            2. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1aHuman pathology and animal models of deep vein thrombosis. \u7b2c41\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. SPC\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff08\u6d25\u5e02\u30016\/20-22, 2019\uff09<\/li>\n
            3. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u8840\u7ba1\u75c5\u7406\u3068\u5fc3\u8840\u7ba1\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\uff1a\u30d7\u30e9\u30fc\u30af\u4ee3\u8b1d\u3068\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0. \u7b2c51\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a\u3001\u7b2c10\u56deJCAC\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff08\u4eac\u90fd\u30017\/11-13, 2019\uff09<\/li>\n<\/ol>\n

              \u5bbf\u984c\u5831\u544a<\/strong><\/p>\n

                \n
              1. \u6d45\u7530\u7950\u58eb\u90ce.\u3000\u8840\u6813\u75c7\u306e\u767a\u751f\u75c5\u7406\u3001\u30a2\u30c6\u30ed\u30fc\u30e0\u8840\u6813\u75c7\u306b\u304a\u3051\u308b\u8840\u6813\u5f62\u6210\u6a5f\u5e8f. \u7b2c108\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\uff08\u6771\u4eac\u30015\/9-11, 2019\uff09<\/li>\n<\/ol>\n

                \u30b9\u30e9\u30a4\u30c9\u30b3\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9<\/strong><\/p>\n

                  \n
                1. \u5927\u6817\u4f38\u884c\uff1a\u76ae\u819a\u816b\u760d\u3000(Adenoid cystic carcinoma of the skin).
                  \n\u7b2c367\u56de\uff08\u5510\u6d25\u8d64\u5341\u5b57\u75c5\u9662\u3001\u5510\u6d25\u5e02\uff09<\/li>\n
                2. \u4e2d\u6751\u6075\u7406\u5b50\uff1a\u4e0b\u773c\u77bc\u816b\u760d (Solitary fibrous tumor).
                  \n\u7b2c368\u56de\uff08\u4e5d\u5dde\u5927\u5b66\u3001\u798f\u5ca1\u5e02\uff09<\/li>\n
                3. \u5927\u6817\u4f38\u884c\uff1a\u53f3\u814e\u816b\u760d\u3000(Tuberous sclerosis complex associated renal cell carcinoma and angiomyolipoma with epithelial cyst).
                  \n\u7b2c370\u56de\uff08\u9577\u5d0e\u5927\u5b66\u3001\u9577\u5d0e\u5e02\uff09<\/li>\n
                4. \u4e2d\u6751\u4fca\u592e\uff1a\u53f3\u819d\u7aa9\u52d5\u8108\u75c5\u5909\u3000(Adventitial cystic disease with thrombus).
                  \n\u7b2c370\u56de\uff08\u9577\u5d0e\u5927\u5b66\u3001\u9577\u5d0e\u5e02\uff09<\/li>\n
                5. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u809d\u816b\u7624\u30fb\u816b\u760d\u3000(Extranodal marginal zone lymphoma of mucosa associated lymphoid tissue).
                  \n\u7b2c371\u56de\uff08\u4e45\u7559\u7c73\u5927\u5b66\u3001\u4e45\u7559\u7c73\u5e02\uff09<\/li>\n
                6. \u5409\u677e\u771f\u4e5f\uff1a\u5de6\u80ba\u9580\u90e8\u816b\u760d (Epithelioid hemangioendothelioma)
                  \n\u7b2c372\u56de\uff08\u5927\u5206\u30a2\u30eb\u30e1\u30a4\u30c0\u75c5\u9662\u3001\u5927\u5206\u5e02\uff09<\/li>\n<\/ol>\n

                  \u53d7\u8cde<\/strong><\/p>\n

                    \n
                  1. \u6d45\u7530\u7950\u58eb\u90ce.\u3000\u4ee4\u548c\u5143\u5e74\u5ea6\u65e5\u672c\u75c5\u7406\u5b66\u8cde
                    \n\u8840\u6813\u75c7\u306e\u767a\u751f\u75c5\u7406\u3001\u30a2\u30c6\u30ed\u30fc\u30e0\u8840\u6813\u75c7\u306b\u304a\u3051\u308b\u8840\u6813\u5f62\u6210\u6a5f\u5e8f<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                    \u539f\u8457\u8ad6\u6587 Kuroiwa Y, Uchida A, Yamashita A, Miyati T, Maekawa K, Gi T, Noguchi T, Yasuda S, Imamura T, Asada Y. Cor … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":96,"featured_media":0,"parent":17,"menu_order":-14,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mi_skip_tracking":false},"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/268"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/users\/96"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/comments?post=268"}],"version-history":[{"count":7,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/268\/revisions"}],"predecessor-version":[{"id":278,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/268\/revisions\/278"}],"up":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/17"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/media?parent=268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}